Thursday 21 June 2018
Contact US    |    Archive
8 months ago

New Options and Evolving Strategies for Hitting the Target in EGFR-Mutant Non–Small-Cell Lung Cancer: Navigating the Transitions in the EGFR TKI Treatment Landscape in the Era of Precision Oncology


Lecia V. Sequist, MD, MPH, Mary Jo Fidler, MD, and Jyoti D. Patel, MD, discuss the management of EGFR-positive NSCLC in this CME/CE activity titled New Options and Evolving Strategies for Hitting the Target in EGFR-Mutant NSCLC: Navigating the Transitions in the EGFR TKI Treatment Landscape in the Era of Precision Oncology. For the full presentation, downloadable Practice Aids, monograph, complete CME/CE information, and to apply for credit, please visit us at http://bit.ly/2hvxFkA. CME/CE credit will be available until October 26, 2018.

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.

Three Drown On Fishing Trip

- malaysiandigest

Balung assemblyman to join PKR

- freemalaysiatoday
Hashtags:   

New

 | 

Options

 | 

and

 | 

Evolving

 | 

Strategies

 | 

for

 | 

Hitting

 | 

the

 | 

Target

 | 

EGFR

 | 

Mutant

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Categories - Countries
All News
Malaysia